Newly diagnosed atrial fibrillation and hospital utilization in heart failure: a nationwide cohort study.


Journal

ESC heart failure
ISSN: 2055-5822
Titre abrégé: ESC Heart Fail
Pays: England
ID NLM: 101669191

Informations de publication

Date de publication:
12 2021
Historique:
revised: 17 09 2021
received: 31 08 2021
accepted: 27 09 2021
pubmed: 3 11 2021
medline: 22 3 2022
entrez: 2 11 2021
Statut: ppublish

Résumé

Atrial fibrillation (AF) constitutes a major burden to health services, but the importance of incident AF in patients with heart failure (HF) is unclear. We examined the associations between incident AF and hospital utilization in patients with HF. In a nationwide matched-cohort study of HF patients, we identified patients diagnosed with incident AF between 2008 and 2018 in the Danish Heart Failure Registry (N = 4463), and we compared them to matched referents without AF (N = 17 802). Incident AF was associated with a multivariable-adjusted 4.8-fold increase (95% CI 4.1-5.6) and 4.3-fold increase (95% CI 3.9-4.8) in the cumulative incidence of inpatient and outpatient contacts within 30 days, respectively. At 1 year, the cumulative incidence ratios were 1.8 (95% CI 1.7-1.9) and 1.4 (95% CI 1.4-1.5). Incident AF was also associated with increases in the total numbers of inpatient and outpatient hospital contacts within 30 days (multivariable-adjusted rate ratio 1.4, 95% CI 1.4-1.5, and 1.6, 95% CI 1.6-1.7, respectively). At 1 year, the ratios were 2.2 (95% CI 2.1-2.3) and 2.0 (95% CI 1.9-2.1). The multivariable-adjusted proportion of bed-day use among HF patients with incident AF was 10.9-fold (95% CI 9.3-12.9) higher at 30 days and 5.3-fold (95% CI 4.3-6.4) higher at 1 year compared with AF-free referents. Incident AF in HF is associated with earlier hospital contact, more hospital contacts, and more hospital bed-days. More evidence on interventions that may prevent the risk and subsequent burden of AF in HF is urgently needed.

Identifiants

pubmed: 34726349
doi: 10.1002/ehf2.13668
pmc: PMC8712819
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4808-4819

Subventions

Organisme : NIA NIH HHS
ID : R01 AG066010
Pays : United States
Organisme : NHLBI NIH HHS
ID : U54 HL120163
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL092577
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL141434
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG066914
Pays : United States

Informations de copyright

© 2021 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.

Références

Eur J Heart Fail. 2021 Mar;23(3):352-380
pubmed: 33605000
Circulation. 2016 Feb 2;133(5):484-92
pubmed: 26746177
Eur Heart J. 2001 Aug;22(15):1318-27
pubmed: 11465964
J Am Coll Cardiol. 2006 May 16;47(10):1997-2004
pubmed: 16697316
J Gerontol A Biol Sci Med Sci. 2001 Mar;56(3):M158-66
pubmed: 11253157
J Am Coll Cardiol. 2017 Nov 14;70(20):2490-2500
pubmed: 29145948
Circulation. 2020 Jun 9;141(23):1915-1926
pubmed: 32511001
Age Ageing. 2019 Mar 1;48(2):196-203
pubmed: 30445608
Circ Cardiovasc Qual Outcomes. 2011 May;4(3):313-20
pubmed: 21540439
Am J Med. 2014 Oct;127(10):963-71
pubmed: 24931393
Circulation. 2020 Mar 3;141(9):e139-e596
pubmed: 31992061
Eur J Prev Cardiol. 2021 Dec 29;28(15):1682-1690
pubmed: 33571994
Scand J Public Health. 2011 Jul;39(7 Suppl):30-3
pubmed: 21775347
BMC Cardiovasc Disord. 2018 May 2;18(1):74
pubmed: 29716540
ESC Heart Fail. 2021 Dec;8(6):4808-4819
pubmed: 34726349
Eur Heart J. 2018 Dec 21;39(48):4277-4284
pubmed: 30325423
JAMA. 2020 Mar 3;323(9):863-884
pubmed: 32125402
Eur Heart J Qual Care Clin Outcomes. 2021 May 07;:
pubmed: 33963404
Circ Arrhythm Electrophysiol. 2021 Jun;14(6):HAE0000000000000078
pubmed: 34129347
Eur Heart J. 2004 Sep;25(18):1614-9
pubmed: 15351160
Circ Heart Fail. 2011 Nov;4(6):740-6
pubmed: 21920917
Circulation. 2014 Jun 10;129(23):2371-9
pubmed: 24842943
J Cardiovasc Med (Hagerstown). 2016 Aug;17(8):608-15
pubmed: 27168141
Circulation. 2002 Dec 10;106(24):3068-72
pubmed: 12473553
Eur Heart J. 2005 Jul;26(13):1303-8
pubmed: 15767288
Age Ageing. 2021 May 5;50(3):772-779
pubmed: 33951158
Clin Epidemiol. 2015 Nov 17;7:449-90
pubmed: 26604824
Circ Heart Fail. 2013 May;6(3):606-19
pubmed: 23616602
Scand J Public Health. 2011 Jul;39(7 Suppl):38-41
pubmed: 21775349
Scand Cardiovasc J. 2017 Aug;51(4):183-189
pubmed: 28366010
Eur J Heart Fail. 2019 Jan;21(1):112-120
pubmed: 30338883
Clin Epidemiol. 2016 Oct 25;8:497-502
pubmed: 27822090
J Gerontol A Biol Sci Med Sci. 2017 Jul 1;72(7):958-964
pubmed: 27733425

Auteurs

Nicklas Vinter (N)

Diagnostic Centre, University Clinic for Development of Innovative Patient Pathways, Silkeborg Regional Hospital, Falkevej 3, Silkeborg, 8600, Denmark.
Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Danish Center for Clinical Health Services Research, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.

Pia Cordsen (P)

Danish Center for Clinical Health Services Research, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.

Gregory Y H Lip (GYH)

Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Chest and Heart Hospital, Liverpool, UK.
Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.

Emelia J Benjamin (EJ)

Department of Medicine, Boston University School of Medicine, Boston, MA, USA.
Department of Epidemiology, Boston University School of Public Health, Boston, MA, USA.

Ludovic Trinquart (L)

Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA.

Søren Paaske Johnsen (SP)

Danish Center for Clinical Health Services Research, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.

Lars Frost (L)

Diagnostic Centre, University Clinic for Development of Innovative Patient Pathways, Silkeborg Regional Hospital, Falkevej 3, Silkeborg, 8600, Denmark.
Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH